Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in treatment-refractory moderate-to-severe Crohn's disease
NCT01233960Phase 3Completed
- Sponsor
- Mesoblast Ltd
- Start
- Nov 2010
- Primary completion
- Sep 2014
- Countries
- 3
01
Overview
A Phase 3 trial of remestemcel-L-rknd in Crohn's disease, sponsored by Mesoblast Ltd. Started Nov 2010; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01233960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233960.